Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I.

Reimand K, Perheentupa J, Link M, Krohn K, Peterson P, Uibo R.

Int Immunol. 2008 Jan;20(1):39-44. Epub 2007 Nov 13.

PMID:
18000009
2.

TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S.

Scand J Immunol. 2011 Feb;73(2):147-53. doi: 10.1111/j.1365-3083.2010.02486.x.

3.

Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.

Bensing S, Fetissov SO, Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M, Ekwall O, Crock PA, Hökfelt T, Hulting AL, Kämpe O.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):949-54. Epub 2007 Jan 10.

4.

Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I.

Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kämpe O.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):456-61.

PMID:
10623641
5.

Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1.

Cocco C, Meloni A, Mariotti S, Cossu E, D'amato F, Zulian S, Tongiorgi E, Ferri GL.

Autoimmunity. 2012 Sep;45(6):485-94. doi: 10.3109/08916934.2012.680632. Epub 2012 May 18.

PMID:
22506635
6.

The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.

Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF, Weetman AP.

J Clin Endocrinol Metab. 2007 Jun;92(6):2107-14. Epub 2007 Mar 20.

PMID:
17374709
7.

Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.

Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.

N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.

8.

Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.

Smith-Anttila CJA, Bensing S, Alimohammadi M, Dalin F, Oscarson M, Zhang MD, Perheentupa J, Husebye ES, Gustafsson J, Björklund P, Fransson A, Nordmark G, Rönnblom L, Meloni A, Scott RJ, Hökfelt T, Crock PA, Kämpe O.

Autoimmunity. 2017 Jun;50(4):223-231. doi: 10.1080/08916934.2017.1332183. Epub 2017 May 30.

PMID:
28557628
9.

Identification of tryptophan hydroxylase as an intestinal autoantigen.

Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kämpe O, Rorsman F.

Lancet. 1998 Jul 25;352(9124):279-83.

PMID:
9690408
10.
11.

Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.

Brozzetti A, Marzotti S, La Torre D, Bacosi ML, Morelli S, Bini V, Ambrosi B, Giordano R, Perniola R, De Bellis A, Betterle C, Falorni A; Italian Addison Network.

Eur J Endocrinol. 2010 Aug;163(2):309-17. doi: 10.1530/EJE-10-0257. Epub 2010 May 24.

PMID:
20498138
12.

Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison's disease.

Brozzetti A, Alimohammadi M, Morelli S, Minarelli V, Hallgren Å, Giordano R, De Bellis A, Perniola R, Kämpe O, Falorni A; Italian Addison Network.

J Clin Endocrinol Metab. 2015 May;100(5):1941-8. doi: 10.1210/jc.2014-3571. Epub 2015 Mar 3.

13.

Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome.

Maclaren N, Chen QY, Kukreja A, Marker J, Zhang CH, Sun ZS.

J Soc Gynecol Investig. 2001 Jan-Feb;8(1 Suppl Proceedings):S52-4. Review.

PMID:
11223374
14.

Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.

Ballarini A, Lee-Kirsch MA.

Ann N Y Acad Sci. 2007 Sep;1110:159-65.

PMID:
17911431
15.

Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.

Ardesjö B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kämpe O, Ekwall O.

J Autoimmun. 2008 Jun;30(4):273-82. doi: 10.1016/j.jaut.2007.11.008. Epub 2008 Feb 1.

PMID:
18242955
16.

Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.

Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M.

J Clin Endocrinol Metab. 2012 Apr;97(4):1114-24. doi: 10.1210/jc.2011-2461. Epub 2012 Feb 16.

PMID:
22344197
17.

Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.

Landegren N, Sharon D, Freyhult E, Hallgren Å, Eriksson D, Edqvist PH, Bensing S, Wahlberg J, Nelson LM, Gustafsson J, Husebye ES, Anderson MS, Snyder M, Kämpe O.

Sci Rep. 2016 Feb 1;6:20104. doi: 10.1038/srep20104.

18.

BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, Lwin W, Perheentupa J, Bour-Jordan H, Carel JC, Husebye ES, De Luca F, Janson C, Sargur R, Dubois N, Kajosaari M, Wolters PJ, Chapman HA, Kämpe O, Anderson MS.

Sci Transl Med. 2013 Oct 9;5(206):206ra139. doi: 10.1126/scitranslmed.3006998.

19.

Autoantibodies in autoimmune polyendocrine syndrome type II.

Falorni A, Laureti S, Santeusanio F.

Endocrinol Metab Clin North Am. 2002 Jun;31(2):369-89, vii. Review.

PMID:
12092456
20.

The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.

Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye E, Gustafsson J, Betterle C, Kämpe O, Rorsman F.

J Biol Chem. 2001 Sep 21;276(38):35390-5. Epub 2001 Jun 22.

Supplemental Content

Support Center